--2025/Q1-- / 0.000--
--2024/Q4-- / 3.156M--
--2024/Q32.910M / 2.234M--
--2024/Q22.364M / 1.867M--
--2024/Q11.029M / 2.800M--
Apple
AAPL
Oracle
ORCL
Adobe
ADBE
Ecopetrol
EC
D.R. Horton
DHI
US Stock MarketDetailed Quotes
IMNM Immunome
- 11.110
- -0.910-7.57%
Close Dec 18 16:00 ET
693.45MMarket Cap-1.40P/E (TTM)
12.140High10.760Low1.08MVolume12.010Open12.020Pre Close12.29MTurnover2.38%Turnover RatioLossP/E (Static)62.42MShares30.95852wk High3.23P/B502.64MFloat Cap8.97052wk Low--Dividend TTM45.24MShs Float63.780Historical High--Div YieldTTM11.48%Amplitude2.090Historical Low11.424Avg Price1Lot Size
Immunome Key Stats
Immunome Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Immunome Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data